Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Non-Current Deferred Tax Liability (2023 - 2025)

Historic Non-Current Deferred Tax Liability for Ascendis Pharma A (ASND) over the last 3 years, with Q4 2025 value amounting to $11.2 million.

  • Ascendis Pharma A's Non-Current Deferred Tax Liability rose 4444.05% to $11.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.2 million, marking a year-over-year increase of 4444.05%. This contributed to the annual value of $10.9 million for FY2025, which is 4021.61% up from last year.
  • As of Q4 2025, Ascendis Pharma A's Non-Current Deferred Tax Liability stood at $11.2 million, which was up 4444.05% from $12.0 million recorded in Q3 2025.
  • Ascendis Pharma A's Non-Current Deferred Tax Liability's 5-year high stood at $12.0 million during Q3 2025, with a 5-year trough of $6.3 million in Q4 2023.
  • Moreover, its 3-year median value for Non-Current Deferred Tax Liability was $8.2 million (2024), whereas its average is $9.1 million.
  • The largest annual percentage gain for Ascendis Pharma A's Non-Current Deferred Tax Liability in the last 5 years was 4444.05% (2025), contrasted with its biggest fall of 568.22% (2025).
  • Quarter analysis of 3 years shows Ascendis Pharma A's Non-Current Deferred Tax Liability stood at $6.3 million in 2023, then grew by 23.64% to $7.8 million in 2024, then soared by 44.44% to $11.2 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $11.2 million for Q4 2025, versus $12.0 million for Q3 2025 and $10.9 million for Q2 2025.